Deciphera Pharmaceuticals, Inc. - FORM 10-K - EX-23.1 - February 9, 2021

Attached files

file filename
EX-32.2 - EX-32.2 - Deciphera Pharmaceuticals, Inc.dcph-20201231xex322.htm
EX-32.1 - EX-32.1 - Deciphera Pharmaceuticals, Inc.dcph-20201231xex321.htm
EX-31.2 - EX-31.2 - Deciphera Pharmaceuticals, Inc.dcph-20201231xex312.htm
EX-31.1 - EX-31.1 - Deciphera Pharmaceuticals, Inc.dcph-20201231xex311.htm
EX-21.1 - EX-21.1 - Deciphera Pharmaceuticals, Inc.dcph-20201231xexx211.htm
EX-10.20 - EX-10.20 - Deciphera Pharmaceuticals, Inc.dcph-20201231xexx1020.htm
EX-10.17A - EX-10.17A - Deciphera Pharmaceuticals, Inc.dcph-20201231xexx1017a.htm
EX-10.17 - EX-10.17 - Deciphera Pharmaceuticals, Inc.dcph-20201231xexx1017.htm
EX-10.16A - EX-10.16A - Deciphera Pharmaceuticals, Inc.dcph-20201231xexx1016a.htm
EX-10.8 - EX-10.8 - Deciphera Pharmaceuticals, Inc.dcph-20201231xexx108.htm
EX-10.7 - EX-10.7 - Deciphera Pharmaceuticals, Inc.dcph-20201231xexx107.htm
EX-10.6 - EX-10.6 - Deciphera Pharmaceuticals, Inc.dcph-20201231xexx106.htm
EX-10.5 - EX-10.5 - Deciphera Pharmaceuticals, Inc.dcph-20201231xexx105.htm
EX-10.4 - EX-10.4 - Deciphera Pharmaceuticals, Inc.dcph-20201231xexx104.htm
EX-10.3 - EX-10.3 - Deciphera Pharmaceuticals, Inc.dcph-20201231xexx103.htm
10-K - 10-K - Deciphera Pharmaceuticals, Inc.dcph-20201231.htm
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-220866, 333-223992, 333-230270, 333-237031) and Form S-3 (No. 333-236389) of Deciphera Pharmaceuticals, Inc. of our report dated February 9, 2021 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 9, 2021

Deciphera Pharmaceuticals, Inc. Reports